Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Chang, S. Liu, H. Wu, J. Xiao, W. Chen, S. Qiu, S. Duan, G. Song, H. Zhang, R.

Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zhu, Y. Liu, S. Zhang, D.

Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Pormohammad, A. Zarei, M. Ghorbani, S. Mohammadi, M. Neshin, S. A. S. Khatami, A. Turner, D. L. Djalalinia, S. Mousavi, S. A. Mardani-Fard, H. A. Kasaeian, A. Turner, R. J.

Effectiveness of covid-19 vaccines against delta (B.1.617.2) variant: A systematic review and meta-analysis of clinical studies

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Mahumud, R. A. Ali, M. A. Kundu, S. Rahman, M. A. Kamara, J. K. Renzaho, A. M. N.

Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Pratama, N. R. Wafa, I. A. Budi, D. S. Sutanto, H. Asmarawati, T. P. Barlian Effendi, G. Wungu, C. D. K.

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Shao, W. Chen, X. Zheng, C. Liu, H. Wang, G. Zhang, B. Li, Z. Zhang, W.

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Variants of Concern in Real-world: a Literature Review and Meta-analysis

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zeng, B. Gao, L. Zhou, Q. Yu, K. Sun, F.

Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ van den Berg, J. M. Remmelzwaal, S. Blom, M. T. van Hoek, Bace Swart, K. M. A. Overbeek, J. A. Burchell, G. L. Herings, R. M. C. Elders, P. J. M.

Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Au, W. Y. Cheung, P. P.

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2022 ∙ Sandoval, C. Guerrero, D. Muñoz, J. Godoy, K. Souza-Mello, V. Farías, J.

Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review

  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...